Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

InnovAge Holding (INNV) EBT (2020 - 2025)

InnovAge Holding (INNV) has disclosed EBT for 6 consecutive years, with $12.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT rose 192.56% year-over-year to $12.5 million, compared with a TTM value of $5.1 million through Dec 2025, up 119.56%, and an annual FY2025 reading of -$34.0 million, down 55.95% over the prior year.
  • EBT was $12.5 million for Q4 2025 at InnovAge Holding, up from $7.9 million in the prior quarter.
  • Across five years, EBT topped out at $12.5 million in Q4 2025 and bottomed at -$17.2 million in Q3 2022.
  • Average EBT over 5 years is -$4.9 million, with a median of -$6.8 million recorded in 2022.
  • The sharpest move saw EBT crashed 683.4% in 2022, then soared 249.19% in 2025.
  • Year by year, EBT stood at $2.3 million in 2021, then plummeted by 683.4% to -$13.5 million in 2022, then skyrocketed by 72.3% to -$3.7 million in 2023, then crashed by 260.97% to -$13.5 million in 2024, then surged by 192.56% to $12.5 million in 2025.
  • Business Quant data shows EBT for INNV at $12.5 million in Q4 2025, $7.9 million in Q3 2025, and -$4.2 million in Q2 2025.